Natrium Chloratum Bbp (Sodium Chloride)

When infused, sodium chloride dissociates into sodium (Na⁺) and chloride (Cl⁻) ions. These ions expand the extracellular fluid space, increase plasma osmolarity, and directly replenish the body’s sodium and chloride stores, helping to maintain vascular volume, nerve conduction, and muscle function.

The dose of Natrium Chloratum Bbp is individualized by the prescribing clinician based on the patient’s fluid status, electrolyte levels, and clinical condition. Healthcare professionals calculate the required volume and concentration to achieve the desired correction of sodium, chloride, and fluid deficits.

Sodium chloride is a naturally occurring electrolyte and is generally considered compatible with pregnancy and lactation when used under medical supervision. However, the prescriber should evaluate the mother’s specific condition and monitor electrolyte levels to avoid over‑correction.

To order Natrium Chloratum Bbp, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Natrium Chloratum Bbp provides standard isotonic sodium chloride without additional additives, making it comparable to conventional 0.9% saline solutions. Its EU‑origin manufacturing ensures compliance with GMP standards, and the product is supplied by GNH India with full regulatory documentation, which may be advantageous for institutions requiring traceable, high‑quality imports.

Store the product at ambient temperature, preferably below 25 °C, in its original sealed container. Protect it from direct sunlight, moisture, and freezing. Follow aseptic techniques during preparation and infusion to maintain sterility and prevent contamination.

Natrium Chloratum Bbp is administered intravenously, either as a continuous infusion or as a bolus, according to the clinician’s order. The infusion rate is adjusted based on the patient’s fluid needs, electrolyte status, and overall clinical response, with regular monitoring of vital signs and laboratory values.

Serious risks include severe hypernatremia, which can cause neurological symptoms such as seizures, pulmonary edema from fluid overload, and cardiac arrhythmias due to rapid electrolyte shifts. Rarely, anaphylactic reactions to preservatives or container materials may occur, necessitating immediate medical intervention.

Patients with known hypersensitivity to sodium chloride preparations, those with uncontrolled severe hypernatremia, or individuals at high risk of fluid overload (e.g., severe heart failure, end‑stage renal disease) should not receive this product unless a careful risk‑benefit assessment is performed by a qualified clinician.